Axovant shares plummet on dementia drug failure
admin 9th January 2018 Uncategorised 0Shares in Axovant Sciences Ltd sank almost 50 percent after investors shrank back on new of the failure of lead drug intepirdine in a mid-stage study in patients with a particular kind of dementia.
More: Axovant shares plummet on dementia drug failure
Source: News